These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13511175)

  • 1. [Rapid aggravation of bronze cirrhosis after a therapeutic trial with a chelating (EDTA calcium)].
    MARTY J; LESTAGE J
    Bull Mem Soc Med Hop Paris; 1958 Jan 10-17; 74(1-2):59-60. PubMed ID: 13511175
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rapid aggravation of 2 cases of pigmentary cirrhosis after trial therapy with a chelator, EDTA calcium].
    KLOTZ HP; AVRIL J; PARIENTE R
    Bull Mem Soc Med Hop Paris; 1957 Nov 15-22; 73(29-30):1001-3. PubMed ID: 13500185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of 6 cases of pigmentary cirrhosis by blood letting & chelating agents].
    VACHON A; LEHMANN M; DHERS A
    Lyon Med; 1958 Mar; 90(12):457-66. PubMed ID: 13540355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Employment of chelating agents of the Calcium E.D.T.A. type during the course of various excessive blood iron conditions].
    LAMACHE A; BOUREL M; VIVIEN P; CORMIER M; LENOIR P; AZARD C; DELAHAYE D
    Sem Med Prof Med Soc; 1957 Feb; 33(7):295-8. PubMed ID: 13421822
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal damage in rats from the lead salt of EDTA and from umbradil.
    IVEMARK B; SELDINGER SI
    Acta radiol; 1957 Nov; 48(5):366-75. PubMed ID: 13497793
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of ethylenediaminetetraacetic acid calcium on the levels of blood iron & urinary iron in 2 cases of idiopathic hemochromatosis].
    CRISMER R; DURIEUX M; DREZE C; DUBOIS J
    Acta Gastroenterol Belg; 1958 Nov; 21(11):704-13. PubMed ID: 13605575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of urinary elimination of iron by a chelate (edathamil calcium) in hemochromatosis].
    AVRIL J; DREUX C; KLOTZ HP; PARIENTE R
    Bull Mem Soc Med Hop Paris; 1956 Oct; 72(24-25):724-7. PubMed ID: 13374539
    [No Abstract]   [Full Text] [Related]  

  • 8. [The heart in bronze cirrhosis].
    LOBRICHON P
    Sem Hop; 1958 Jan; 34(5):295-7. PubMed ID: 13580298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chelating agents in hemochromatosis; therapeutic method or diagnostic test].
    WATER J; WEILL JP
    Presse Med (1893); 1957 Aug; 65(60):1371-3. PubMed ID: 13477735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Idiopathic hemochromatosis. Therapeutics].
    Pergola F
    Presse Med (1893); 1967 May; 75(24):1221-2. PubMed ID: 4960744
    [No Abstract]   [Full Text] [Related]  

  • 11. The diagnostic and therapeutic use of edathamil calcium disodium (EDTA, versene) in excessive inorganic lead absorption.
    LECKIE WJ; TOMPSETT SL
    Q J Med; 1958 Jan; 27(105):65-82. PubMed ID: 13506011
    [No Abstract]   [Full Text] [Related]  

  • 12. Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA.
    Lanigan RS; Yamarik TA
    Int J Toxicol; 2002; 21 Suppl 2():95-142. PubMed ID: 12396676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gas gangrene septicemia during the course of a diabetic coma in a patient with bronze cirrhosis].
    BARRES G; BINET L; BOUR H
    Prog Med (Paris); 1956 Nov; 84(21):391-2. PubMed ID: 13389566
    [No Abstract]   [Full Text] [Related]  

  • 14. EDTA-dependent pseudothrombocytopenia in a case of liver cirrhosis.
    Matarazzo M; Conturso V; Di Martino M; Chiurazzi F; Guida G; Morante R
    Panminerva Med; 2000 Jun; 42(2):155-7. PubMed ID: 10965778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemochromatosis with severe arrhythmias. Favourable response under the influence of treatment with disodic calcitetracemate].
    Orjebin P
    Ann Cardiol Angeiol (Paris); 1971; 20(3):253-60. PubMed ID: 4997674
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chelating agents in the therapy of hemochromatosis. Comments on a case after one year of treatment].
    ALTAVA V; GOMEZ E
    Med Esp; 1960 Aug; 44():122-4. PubMed ID: 13682709
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of unithiol and CaNa2 EDTA on the urinary elimination of trace elements in the dog].
    Soroka VR; Sorokina AA
    Gig Tr Prof Zabol; 1969 Jun; 13(6):40-1. PubMed ID: 4979140
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the effect of Fe-3-Specific, versenol, and calcium disodium versenate on urinary iron excretion in a patient with hemochromatosis.
    MCMAHON FG
    J Lab Clin Med; 1956 Oct; 48(4):589-602. PubMed ID: 13367597
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin D2 poisoning with considerable hypercalcemia; immediate disappearance of clinical and humoral disorders under the effect of a chelator (EDTA)].
    RICHET G; FRITEL D
    Bull Mem Soc Med Hop Paris; 1957 Mar 22-Apr 12; 73(11-13):361-7. PubMed ID: 13437148
    [No Abstract]   [Full Text] [Related]  

  • 20. [Testicular insufficiency in bronze hemochromatosis: 14 case reports].
    GILBERT-DREYFUS ; SAVOIE JC
    Sem Hop; 1954 Oct; 30(63):3527-41. PubMed ID: 13216269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.